Skip to main content

Nonprofit · EIN 46-4555214

PHARMACEUTICAL PRODUCT STEWARDSHIP WORK GROUP

Tax-exempt · WASHINGTON, DC 20036

Financials

$4.1M$3.7M2023$5M$3.6M2024
Revenue Expenses · by fiscal year end
Financials of PHARMACEUTICAL PRODUCT STEWARDSHIP WORK GROUP by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2024990$4,990,661$3,589,528$1,401,133$14,209,273$8,461,416$5,747,857
December 31, 2023990$4,070,019$3,741,383$328,636$22,293,395$17,946,671$4,346,724
Financial details: 990 for the year ended December 31, 2024

Revenue

Contributions, gifts and grants
$0
Program service revenue
$4,886,358
Investment income
$81,239
Other revenue
$23,064

Expenses

Grants and similar amounts paid
$0
Salaries, compensation and benefits (total)
$0
Professional fundraising fees
$0
Legal fees
$242,787
Accounting fees
$49,489
Travel
$10,390
Depreciation
$29,455

Balance sheet and other

Total assets, start of year
$22,293,395
Total assets, end of year
$14,209,273
Total liabilities, end of year
$8,461,416
Net assets, end of year
$5,747,857
Net assets without donor restrictions
$5,747,857
Gross receipts
$4,990,661
Employees
0
Volunteers
9
Year formed
2014
State of legal domicile
DC

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2024, highest compensation first.

NameTitleHours / weekCompensation
KATE KULESHERCHAIR (AS OF 06/24)
Trustee or director, Officer
0.75$0
MATT BADALUCCOVICE CHAIR
Trustee or director, Officer
0.75$0
COLIN CHILESPAST CHAIR
Trustee or director, Officer
0.5$0
SHAWN BROWNSECRETARY/TREASURER
Trustee or director, Officer
0.5$0
STACY BURCHDIRECTOR
Trustee or director
0.5$0
BEENA PATELDIRECTOR
Trustee or director
0.5$0
DREW REAVISDIRECTOR
Trustee or director
0.5$0
ANNE MURRAYDIRECTOR
Trustee or director
0.5$0
ANNE VOGEL-MARREXECUTIVE DIRECTOR
Officer
40$0
IRINA BUTLERDEPUTY EXECUTIVE DIRECTOR
Officer
40$0
MELISSA LETENDREVICE PRESIDENT, FINANCE
Officer
40$0
990 for the year ended December 31, 2023: 11 people
NameTitleHours / weekCompensation
COLIN CHILESCHAIR
Trustee or director, Officer
0.4$0
ANNE MURRAYPAST CHAIR
Trustee or director, Officer
0.4$0
BARBARA MORROWVICE CHAIR
Trustee or director, Officer
0.4$0
SHAWN BROWNSECRETARY/TREASURER
Trustee or director, Officer
0.4$0
BEENA PATELDIRECTOR
Trustee or director
0.4$0
STEVE GIULIDIRECTOR
Trustee or director
0.4$0
KATE KULESHERDIRECTOR
Trustee or director
0.4$0
DREW REAVISDIRECTOR
Trustee or director
0.4$0
TRAVIS SHAWDIRECTOR
Trustee or director
0.4$0
ANNE VOGEL-MARREXECUTIVE DIRECTOR
Officer
40$0
MELISSA LETENDREVICE PRESIDENT, FINANCE
Officer
40$0

Address and contacts

Address (IRS master file)
1800 M STREET NW SUITE 400 SOUTH, WASHINGTON, DC 20036-5878
In care of
% JOHN FLATLEY
Principal officer (990 for 2024)
IRINA BUTLER, 1800 M STREET NW SUITE 400 SOUTH, WASHINGTON, DC 20036
Signed the 990
IRINA BUTLER, EXECUTIVE DIRECTOR
Phone
(202) 495-3131
Return prepared by
CLIFTONLARSONALLEN LLP

Mission

FACILITATE THE APPROPRIATE AND EFFICIENT DISPOSAL OF UNWANTED HOUSEHOLD MEDICINES AND HOME GENERATED SHARPS BY PROVIDING INFRASTRUCTURE, GUIDANCE, AND SUBJECT MATTER EXPERTISE TO SUPPORT MEMBER COMPLIANCE AND IMPROVE AWARENESS OF EXISTING PHARMACEUTICAL DISPOSAL OPTIONS.

990 for the year ended December 31, 2024

Program accomplishments

  • COMMUNICATION AND PROGRAM ADMINISTRATION: PPSWG PROVIDES A FORUM TO DEVELOP CONSENSUS AMONG PHARMACEUTICAL AND SHARPS MANUFACTURERS AND A FRAMEWORK FOR ADDRESSING COMPLIANCE WITH HOUSEHOLD-GENERATED UNWANTED PHARMACEUTICAL AND SHARPS PRODUCTS STEWARDSHIP LEGISLATION THROUGH ACTIVE MEMBER ENGAGEMENT. PPSWG RAISES PUBLIC AWARENESS ABOUT THE APPROPRIATE DISPOSAL METHODS FOR HOUSEHOLD-GENERATED UNWANTED PHARMACEUTICAL AND SHARPS PRODUCTS.

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026Not on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
46-4555214
Tax-exempt status
501(c)(6): Business league or chamber of commerce
Donations deductible
No
Exempt since
2016
Accounting year ends
December
Files
Form 990 or 990-EZ
Assets (IRS master file)
$14,209,273
Income (IRS master file)
$4,990,661

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2024$4,990,661$3,589,528$14,209,273IRS
990December 2023$4,070,019$3,741,383$22,293,395XML
990December 2022$4,574,979$3,991,401$23,702,827IRS
990December 2021–––IRS
990December 2020–––IRS
990December 2018–––IRS
990December 2017–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 46-4555214).

Questions about PHARMACEUTICAL PRODUCT STEWARDSHIP WORK GROUP

What is the EIN of PHARMACEUTICAL PRODUCT STEWARDSHIP WORK GROUP?
The employer identification number (EIN) of PHARMACEUTICAL PRODUCT STEWARDSHIP WORK GROUP is 46-4555214.
Is PHARMACEUTICAL PRODUCT STEWARDSHIP WORK GROUP tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(6) since 2016.
Are donations to PHARMACEUTICAL PRODUCT STEWARDSHIP WORK GROUP tax-deductible?
No. The IRS master file says contributions to it are not deductible.
Which annual return does PHARMACEUTICAL PRODUCT STEWARDSHIP WORK GROUP file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of PHARMACEUTICAL PRODUCT STEWARDSHIP WORK GROUP due?
The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
When did PHARMACEUTICAL PRODUCT STEWARDSHIP WORK GROUP last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2024.
Who is the principal officer of PHARMACEUTICAL PRODUCT STEWARDSHIP WORK GROUP?
The 990 for the year ended December 31, 2024 names IRINA BUTLER.
Who are the officers and directors of PHARMACEUTICAL PRODUCT STEWARDSHIP WORK GROUP?
The 990 for the year ended December 31, 2024 lists 11 people; 0 received compensation from the organization.
How much revenue does PHARMACEUTICAL PRODUCT STEWARDSHIP WORK GROUP have?
On its 990 for the year ended December 31, 2024 it reported revenue of $4,990,661, expenses of $3,589,528 and total assets of $14,209,273 at year end.

Other nonprofits in WASHINGTON

All nonprofits in WASHINGTON · District of Columbia · Community improvement and capacity building